Axel Grothey

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database”.

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database

Annals of Oncology(2020)10.1016/j.annonc.2019.12.007

N/A

1.4DataRank · unranked

34 citations

Jun Yin, Richard M. Goldberg, Levi Pederson, Norman Wolmark, Steven R. Alberts +11 more

A new prognostic and predictive tool for shared decision making in stage III colon cancer

European Journal of Cancer(2020)10.1016/j.ejca.2020.07.031

N/A

0.639DataRank · unranked

70 citations

Alberto Puccini, Qian Shi, Axel Grothey, Thierry André, Anthony F. Shields +6 more

Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4003

N/A

0DataRank · unranked

3 citations

Qian Shi, Charles S. Fuchs, Donna Niedzwiecki, Tyler Zemla, Priya Kumthekar +15 more

Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741

UNC Libraries(2020)10.17615/dcyd-pm18

N/A

0DataRank · unranked

0 citations

Daniel J. Sargent, Sharon Marsh, B. Findlay, Cristi R. King, Axel Grothey +8 more

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

UNC Libraries(2020)10.17615/23jw-by02

N/A

0DataRank · unranked

0 citations

Qian Shi, Axel Grothey, Jan Franko, Richard M. Goldberg, Daniel J. Sargent +5 more

Clinical and Functional Characterization of Atypical KRAS / NRAS Mutations in Metastatic Colorectal Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0180

N/A

0DataRank · unranked

39 citations

Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more

Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS–MAPK pathway and TP53 as potential predictors of immunotherapy efficacy

Annals of Oncology(2021)10.1016/j.annonc.2021.03.203

N/A

0DataRank · unranked

26 citations

Joanne Xiu, Yasmine Baca, Hiroyuki Arai, Francesca Battaglin, Natsuko Kawanishi +17 more

Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients

npj Precision Oncology(2021)10.1038/s41698-021-00230-y

N/A

0DataRank · unranked

19 citations

Andreas Seeber, Joanne Xiu, Richard M. Goldberg, Davide Soldato, Axel Grothey +16 more

Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab187

N/A

0DataRank · unranked

16 citations

Mohamed E. Salem, Jesse G. Dixon, Zhaohui Jin, Romain Cohen, Aimery DeGramont +16 more

Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study

The Lancet Oncology(2023)10.1016/s1470-2045(22)00783-5

N/A

0DataRank · unranked

85 citations

Joanne Xiu, Alex Farrell, Yasmine Baca, Hiroyuki Arai, Francesca Battaglin +19 more

Data from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6530433

N/A

0DataRank · unranked

0 citations

Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more

Data from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6530433.v1

N/A

0DataRank · unranked

0 citations

Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more

Relationship between MLH1, PMS2, MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors

International Journal of Cancer(2020)10.1002/ijc.33115

N/A

0DataRank · unranked

167 citations

J. Nicholas Bodor, Alberto Puccini, Joanne Xiu, Richard M. Goldberg, Axel Grothey +8 more

Phase I–II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors

Cancer Chemotherapy and Pharmacology(2024)10.1007/s00280-024-04714-z

N/A

0DataRank · unranked

2 citations

Axel Grothey, Darren Sigal, Heinz-Josef Lenz, Howard S. Höchster, Yee Chao +5 more

Overall survival (OS) and long-term disease-free survival (DFS) of three versus six months of adjuvant (adj) oxaliplatin and fluoropyrimidine-based therapy for patients (pts) with stage III colon cancer (CC): Final results from the IDEA (International Duration Evaluation of Adj chemotherapy) collaboration.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4004

N/A

0DataRank · unranked

36 citations

Thierry André, Jeffrey A. Meyerhardt, Axel Grothey, Timothy Iveson, Takayuki Yoshino +15 more